Aarti Drugs informs about disclosure

07 May 2025 Evaluate

In continuation to its intimation dated August 3, 2024 vide reference number ADL/SE/2024- 25/51 and February 7, 2025 vide reference number ADL/SE/2024-25/131, Aarti Drugs has informed that the Company had filed a writ petition in ‘The High Court of Judicature at Bombay’ to challenge the order passed by CGST & C.Ex. Authority. The Hon’ble Court has passed the order granting the ad-interim relief directing the CGST & C.Ex. Authority not to initiate coercive action for recovery of the amount mentiond in order passed by CGST & C.Ex. Authority. The requisite information as per Para A of Part A of Schedule III under Regulation 30 of the Listing Regulations is enclosed. The additional information pursuant to Industry Standards Note on Regulation 30 of the Listing Regulations is provided under Annexure A. The company will update the exchanges on any further updates.

The above information is a part of company’s filings submitted to BSE.

Aarti Drugs Share Price

404.95 -3.35 (-0.82%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×